Effective dry eye care in primary practice requires treatment strategies that are realistic, adaptable, and sustainable for both the clinician and the patient. This course focuses on the practical management of dry eye disease in the primary care optometric setting. Practitioners will learn about treatment selection, patient education and follow up guidelines. Attendees will gain strategies to improve patient adherence, set realistic expectations, recognize when escalation of care is needed, and manage dry eye as a chronic condition within a busy practice environment.

Join Woo University’s Future Eyes Summit — a high-impact, half-day virtual event designed exclusively for 3rd/4th year optometry students and new grads. No fluff. Just real-world strategies, candid advice, and clinical + career clarity to help you launch a new chapter with confidence.

Dry eye disease is one of the most common conditions encountered in primary eye care, yet diagnosis can feel challenging in busy clinics. This course simplifies the process by providing a systematic approach to diagnosis. 

Join Woo U for a unique Scleral Lens "Office Hours", where practitioners are encouraged to submit real clinical cases of specialty contact lens patients where they experience a challenge or difficulty in the fitting process. Several cases will be selected and presented to a live panel of specialty lens experts who will then review each case and provide feedback. Attendees will have the opportunity to participate in a live interaction with the experts by asking live questions and gathering expert insights.

The most recent addition to our treatment armamentarium for presbyopia is the use of pharmaceutical agents that induce pupil miosis which results in an extended depth of focus to improve near vision. Contact lenses have been a mainstay in presbyopia management. This course will explore how new pharmaceutical options can optimize outcomes in the treatment of presbyopia when used in combination with a variety of contact lens modalities.   

Presbyopia is a condition that affects nearly everyone over the age of 45.   Traditional treatment options like eyeglasses and contact lenses  are not ideal options for all patients.  Recently pharmacologic options have come to the market.  This lecture will review and update the pharmacologic treatment options for presbyopia. 

This course highlights the intersection of eye care and whole-body wellness, examining how visual dysfunction can contribute to widespread public health issues such as chronic headache, dizziness, car sickness, and neck pain. Through an integrative optometry lens, participants will explore diagnostic strategies, therapeutic interventions, and collaborative care models that address both visual and systemic symptoms to improve patient quality of life.

Dry eye is a multifactorial disease with numerous diagnostic and treatment options available. This lecture will discuss novel treatment strategies for ocular surface disease/DED. Treatment options covered will include pharmacologic agents, amniotic membranes, intense pulsed light, radiofrequency, photobiomodulation, and meibomian gland expression technologies.

Getting the perfect fit achieved for you specialty lens patient is just the beginning.  In order for the patient to be successful, you have to make sure that the eyes and the lenses are being properly cared for in order to maximize the patient experience and maximize your practice’s revenue potential.   

A correct and timely diagnosis of dry eye is essential in deciding on the protocol for treatment. Learn best practices in patient questionnaires and surveys, clinical signs, and symptoms, and using tools and technology to assess and ensure prompt dry eye diagnosis. Also to be discussed are common challenges in dry eye diagnosis, including possible masqueraders.

This course provides a practical, evidence informed framework for optometrists to evaluate, initiate, and monitor pharmacologic treatment for presbyopia. Through a structured, step by step approach, clinicians will learn how to identify ideal candidates, conduct baseline testing, implement safe prescribing protocols, and manage patient follow-up. Emphasis will be placed on patient centered care and how to counsel patients on realistic expectations for a successful outcome. 

Everyone is going to get cataracts, everyone is going to get presbyopic and everyone will get dry eye syndrome. This course will focus on real world management and what is new for the practical approach to dry eye. 

A comprehensive overview of contact lens complications in primary care optometry, includingsoft, RGP, hybrid, and scleral lenses, with emphasis on clinical recognition, differentialdiagnosis, patient management, and prevention strategies.

Presbyopia is a condition that affects nearly everyone over the age of 45. Traditional treatment options like eyeglasses and contact lenses are not ideal options for all patients. Recently pharmacologic options have come to the market. This lecture will review and update the pharmacologic treatment options for presbyopia.

Explore cutting edge keratoconus research and the breakthroughs shaping tomorrow’s treatments.

This educational symposium featuring expert presentations and discussion will enable improved understanding of the comparative utility of presbyopia treatments and foster informed discussions around optimizing outcomes.

Join Woo University for a focused 4-hour deep dive into oral and topical ophthalmic pharmacology. On Sunday, November 23rd, 2025, attendees will hear from leading experts Dr. Jessica Steen and Dr. Nidhi Rana as they cover the latest therapeutic updates and essential pediatric pharmacological considerations. Moderated by Dr. Jennifer Stewart, this program offers high-yield, clinically relevant content designed to elevate your patient care. Early Prepared Pupil pricing is just $39 until November 7th, with full access to both sessions included.

Dive into the fascinating science behind visual perceptual learning in managing various visual conditions, and how it harnesses the brain’s neuroplasticity to improve visual function. This course explores key neurobiological principles, reviews pivotal clinical studies supporting the efficacy of these innovative therapies, and patient selections. Learn how unique visual cortex training differs from traditional vision therapy and the implications for clinical practice.

This course examines approved and investigational pharmacologic therapies for presbyopia, with focus on efficacy, safety, patient selection, and integration into clinical practice.

More than 50% of the patient experience happens outside the physical exam room. This course provides a roadmap for integrating artificial intelligence (AI) into every phase of your operations—from marketing and scheduling to post-visit follow-up. Attendees will learn how to strategically deploy AI to reduce administrative burden, improve patient retention, and increase revenue—all while future-proofing their practices. This is not a clinical course—it’s a business growth playbook for forward-thinking professionals ready to lead their practices into the future.

This course reviews current diagnostic and management strategies for keratoconus, including advances in imaging, corneal biomechanics, and collagen cross-linking. Participants will gain practical insights to improve early detection, personalize treatment, and optimize visual outcomes.

Managing presbyopia requires thoughtful care. This session reviews current options—devices, surgery, and new pharmaceuticals—while emphasizing teamwork between providers. Participants will gain strategies for optimizing outcomes, addressing challenges, and enhancing co-management to achieve the best results for patients. 

Kayla Ashlee, founder of Spexy and a certified optician, is a bold industry innovator and international speaker known for challenging the status quo. Through her energetic, practical approach, she turned years of coaching experience into Spexy®—an online training platform that empowers eyecare teams to boost patient care, connection, and profitability. Join her at LOFT Santa Monica for accredited CE classes designed to inspire real change in optical practices.

As our understanding of ocular surface physiology continues to evolve, so do the diagnostics and therapeutics we have available to manage dry eye disease. This course will highlight clinically relevant pearls for diagnosing and treating dry eye.

Scleral lenses are not always the answer for irregular cornea patients. During this course, we will review several common complex cornea cases and discuss why a corneal GP lens is the best option. Learn when to use a corneal GP lens instead of a hybrid, custom soft, or scleral lens design.

This course will cover cataract surgery and the implantable lens options available to patients. The course will discuss how to weed through multifocal and extended depth of focus premium cataract implants. The course will cover differences in appearance under slit lamp and what vision ranges a patient can expect from each lens implant.

This course will review several types of patient candidates for corneal GP lenses including spherical GP, Toric GP, Bitoric GP, Back Toric GP, and Multifocal Cornea GPs. We will review several case studies who identify the best candidates for each lens design.

Optometry’s role in retinal disease management is significant and critical. It extends from diagnosis involving advanced technologies to management across the spectrum of systemic diseases like diabetes, slowing dry AMD progression, knowing what and when to refer versus when to observe. This course emphasizes the clinical skills needed for diagnosis and management of AMD and diabetic retinopathy and shows why optometry must play the key role in retinal disease cases.

This course reviews the latest pharmacologic approaches to presbyopia, focusing on mechanisms of action, efficacy, safety profiles, and practical prescribing considerations to help clinicians match treatments to individual patient needs.   

Dry eye disease significantly affects vision and quality of life. Autologous serum eye drops (ASED) offer growth factors and anti-inflammatory benefits for moderate to severe cases. This lecture reviews dry eye subtypes, serum composition, and prescribing protocols, guiding attendees on integrating ASEDs into personalized care.